TearScience Receives $70M in Funding

TearScience, a medical device company based in Morrisville, N.C., has received up to $70 million from HealthCare Royalty Partners in order to market the TearScience system for people suffering from dry eye conditions.

Advertisement

The TearScience system is designed to help physicians diagnosis and treat dry eye conditions.

HealthCare Royalty Partners, based in Stamford, Conn., is an international healthcare investment firm.

More Articles on Ophthalmology:
American Academy of Ophthalmology Joins Choosing Wisely Campaign
Lahey Hospital & Medical Center Acquires Essex VitreoRetinal Services
California Laws Prohibiting ‘One-Stop- Optician Stores Remain Intact

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.